"The favorable tolerability and pharmacokinetic profile observed with CVN293 in this first-in-human study are promising ...

Northwestern Medicine investigators have discovered previously unknown metabolic changes that may contribute to the ...

Aidan Hanna jumped out of his chair, ran out of his room and through the hallway in his house and back, with his hands on his ...

A decade-long study found that obesity was associated with a significantly increased risk for biologic treatment failure in ...

Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on April 3, 2025, the Company’s Board of Directors approved ...

Shift your mindset and unlock your body's potential for better health. See how a small mental change can lead to big results.

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

BACKGROUND: Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and dementia. We examined whether an increased genetic risk for CAD is ...